Nanoparticle Size & Distribution Analysis

Nanoparticle Size & Distribution Analysis

Nanoparticle size and distribution analysis measures not just the average size of particles in a sample, but the full range and spread of sizes present – revealing whether a population is uniform (monodisperse) or heterogeneous (polydisperse). This distinction matters because two samples with an identical average size can behave very differently if one is tightly uniform and the other contains multiple subpopulations or aggregates.

Why Is Nanoparticle Size Distribution Important?

Accurate size measurement and distribution analysis are fundamental to nanoscale research and therapeutic development. Size-dependent properties govern biological interactions, material performance, and regulatory compliance across pharmaceutical, environmental, and materials science applications.

• Size as a determinant of functional behavior — Even a 10–20 nm change in particle diameter can alter catalytic activity, optical properties, and biological uptake.
• Size-dependent pharmacokinetics in drug delivery — In targeted systems, particles ranging from 80 to 120 nm exhibit optimal tumor accumulation due to enhanced permeability and retention. Smaller particles (<50 nm) clear quickly through the kidneys, while larger particles (>200 nm) are sequestered in the liver and spleen.
• Distribution characteristics and system uniformity — A monodisperse population behaves predictably and uniformly; polydisperse formulations introduce heterogeneity that compromises performance consistency, and subpopulations within a distribution may exhibit distinct biological fates that complicate dose-response relationships or trigger unintended immune responses.
• Regulatory expectations — Agencies including the FDA, EMA, and ICH require consistent particle size distribution data to ensure product stability, reproducibility, and safety throughout a nanomedicine’s lifecycle.
• Environmental behavior — Nanoparticle aggregation, transport, and bioaccumulation in natural systems depend on particle size; accurate measurement clarifies how materials behave across changing chemistries and pH conditions.
• Material and optical properties — Quantum dots tune fluorescence through size variation, and plasmonic and catalytic nanoparticles show optical and reactivity shifts that scale with particle diameter.
• Surface area and reactivity — Smaller nanoparticles exhibit exponentially higher surface-to-volume ratios, influencing dissolution rates, reaction kinetics, and cellular interactions.
• Protein corona formation — When nanoparticles enter biological fluids, proteins adsorb onto their surfaces; smaller particles bind proportionally more protein, altering effective hydrodynamic size and biological identity. Tracking these shifts reveals critical information about nanoparticle stability and uptake pathways.

Key Parameters Measured in Nanoparticle Size Analysis

• Mean/median size — the central tendency of the size distribution
• Distribution width and shape — described using standard deviation and percentile values such as D10, D50, and D90
• Polydispersity — the degree to which a sample deviates from a single uniform size
• Subpopulation presence — minority populations (aggregates, contaminants, or distinct particle species) that may be masked in an averaged measurement

How Nanoparticle Tracking Analysis (NTA) Measures Particle Size

(For the full physics behind NTA’s size calculation, see the NTA fundamentals guide.)

NTA measures each particle individually rather than relying on a population average. Software algorithms track thousands of individual particles simultaneously, calculating size from each particle’s Brownian motion using the Stokes-Einstein equation. Because every tracked particle contributes its own individual size value to the final result, NTA produces a true size distribution — including subtle subpopulations that ensemble techniques can miss entirely.

Understanding Particle Size Distribution: Monodisperse vs. Polydisperse

• Monodisperse samples contain particles of essentially uniform size. These populations behave predictably, and a single mean size value is a reasonably complete description of the sample.
• Polydisperse samples contain a meaningful spread of particle sizes, sometimes including entirely distinct subpopulations. A mean value alone can be misleading for a polydisperse sample — two very different populations can average to the same reported “mean size” while behaving completely differently in practice.

Real-world samples — particularly biological ones like liposomes, exosomes, and viral vector preparations — are frequently polydisperse, which is exactly where particle-by-particle techniques like NTA provide the most value over ensemble averaging methods like DLS.

Why Choose Envision NTA for Nanoparticle Size & Distribution Analysis?

Envision NTA addresses the challenges of size and distribution measurement through:

• Individual particle resolution — measuring each particle individually rather than only providing population averages, revealing true size distributions including subtle subpopulations other methods might miss
• Fluorescence mode — enabling selective tracking of labeled particles within complex mixtures
• Transparent, automated software — algorithms track thousands of individual particles simultaneously, calculating size from movement patterns via the Stokes-Einstein equation, with adjustable analysis parameters that let you see exactly how the algorithm tracks particles and makes size calculations — supporting both method validation and regulatory compliance documentation
• High-resolution distribution profiling — resolving complex multimodal distributions and detecting minor populations critical for identifying contaminants, aggregates, or formulation heterogeneity

Common Challenges in Nanoparticle Size Measurement

• Heterogeneity complicates measurement — real-world samples rarely contain perfectly uniform particles; polydisperse populations introduce overlapping scattering signals that make it difficult to extract accurate size data using ensemble techniques
• Ensemble methods can mask subpopulations — techniques like DLS provide intensity-weighted averages, overrepresenting larger particles and obscuring small but critical populations that influence behavior or stability
• Sample preparation can distort results — drying, staining, or immobilizing nanoparticles for microscopy often alters their natural state, especially for soft or hydrated systems such as liposomes or polymeric carriers
• Environmental factors affect diffusion — temperature, viscosity, and ionic strength all influence Brownian motion; even slight variations during measurement can lead to inconsistent size estimation if not properly controlled
• Aggregation and sedimentation interfere — nanoparticles may aggregate or settle due to gravity in suspension, producing misleading distributions
• Limited dynamic range in traditional tools — many techniques struggle to measure both small nanoparticles and larger aggregates in a single run, leaving gaps in the true distribution
• Refractive index dependence skews accuracy — optical methods relying on light intensity often misrepresent particles with low refractive contrast, such as lipid or polymer nanoparticles, leading to apparent undercounting
• Statistical confidence requires sufficient sampling — ensemble averages hide variability, while single-particle methods can suffer from a limited field of view; the ideal approach provides statistically meaningful data from individual particle tracking at scale

Factors Affecting Nanoparticle Size Measurement Accuracy

• Sample concentration — too concentrated causes particle images to overlap and creates tracking errors; too dilute provides inadequate statistics
• Temperature control — directly affects solution viscosity and particle diffusion rates, and therefore calculated size
• Sample viscosity — the Stokes-Einstein equation requires accurate viscosity input; this is rarely an issue for aqueous solutions but becomes important for organic solvents or high-concentration buffers
• Refractive index of the material — affects the practical lower detection limit; lower-refractive-index materials such as lipids or proteins are harder to detect at very small sizes than higher-refractive-index materials
• Sample preparation and handling — bubbles, debris, or inconsistent dilution all introduce measurement error independent of the instrument itself

Typical Nanoparticle Size Analysis Workflow

1. Sample dilution — the sample is diluted, if needed, into the instrument’s optimal concentration range for individual particle tracking
2. Sample loading — a small volume is loaded into the measurement cell
3. Real-time tracking feedback — live particle tracks confirm appropriate concentration before a full measurement is captured
4. Brownian motion tracking — the system records and tracks each particle’s motion across video frames
5. Size calculation — each particle’s diffusion coefficient is converted to a hydrodynamic diameter via the Stokes-Einstein equation
6. Distribution compilation — individual particle sizes are compiled into a full size distribution, revealing mean size, spread, and any distinct subpopulations
7. Interpretation — results are compared against expected ranges, prior batches, or regulatory specification limits as relevant to the application

Applications of Nanoparticle Size & Distribution Analysis

Pharmaceutical formulation development Drug delivery nanoparticles must meet strict size specifications. Liposomal formulations, which often contain multiple lamellae, are inherently polydisperse — NTA resolves individual liposome populations, revealing how formulation variables affect size distribution, so lipid ratios, production methods, and storage conditions can be optimized based on real distribution data. For mRNA lipid nanoparticles in vaccines, maintaining the right particle size is critical: sizes below the optimal range result in rapid clearance, while larger particles exhibit reduced targeting efficiency. NTA supports quality control by verifying particle size uniformity across batches.

Nanomedicine and regulatory support NTA data supports regulatory submissions by providing detailed size distribution profiles and concentration measurements. Stability studies benefit substantially from NTA’s ability to detect early-stage aggregation — even a slight shift toward larger sizes or a decrease in particle count can be an early warning sign, enabling timely intervention before stability failure occurs. For generic nanomedicines, matching only the average size is insufficient; NTA provides the detailed distribution data necessary for meaningful comparison.

Virus and gene therapy vectors Adeno-associated viruses (AAVs), lentiviruses, and other viral vectors are typically 20–100 nm and expensive to produce, with quality directly impacting therapeutic efficacy and safety. NTA quantifies both full and empty capsids based on subtle size differences — an important distinction, since empty capsids compete for cell binding without delivering the therapeutic gene. See also our virus and virus-like particle page.

Exosome and extracellular vesicle research Exosomes and EVs are central to studies of cell communication, disease mechanisms, and emerging therapeutic delivery, and their heterogeneity makes them difficult to characterize using ensemble techniques. NTA differentiates exosomes (30–150 nm) from larger microvesicles (100–1000 nm) and protein aggregates, providing true particle-by-particle size distributions that reflect the actual biological sample rather than relying on model assumptions.

Nanomaterial environmental and toxicological studies NTA enables direct measurement of nanoparticles in complex matrices such as seawater, soil extracts, or biological fluids, tracking aggregation, dissolution, and corona formation as proteins or salts interact with particle surfaces — revealing how nanoparticles behave under real-world environmental and physiological conditions.

Food science and beverage applications Food and beverage formulations increasingly use nanoemulsions and lipid carriers to deliver nutrients and flavors. NTA quantifies particle size and distribution in systems such as milk and coffee, where submicron fat globules and dispersed oils govern texture, flavor, and product consistency.

Colloid and surface chemistry research Fundamental studies of colloidal systems benefit from NTA’s ability to track individual particles — aggregation kinetics, surface charge effects, and stabilization mechanisms all manifest as changes in size distribution over time. Gold nanoparticles, quantum dots, and other inorganic nanoparticles often show complex aggregation behavior; NTA reveals how synthesis conditions, surface coatings, and storage conditions affect colloidal stability, feeding back into improved synthesis protocols.

NTA vs. DLS for Nanoparticle Size Distribution

DLS reports an intensity-weighted average across the entire sample, which overrepresents larger particles and can obscure smaller but important populations — a significant limitation for polydisperse samples where distribution shape, not just average size, is the point of the measurement. NTA’s particle-by-particle approach avoids this by reporting every tracked particle’s size individually.

NTA vs. SEM/TEM for Nanoparticle Size Analysis

SEM and TEM provide direct visual confirmation of particle size and shape at high resolution, but require dried, fixed samples under vacuum — an environment that can alter soft or hydrated particles such as liposomes and provides no distribution data across a statistically large population in the way NTA’s automated particle-by-particle tracking does.

Why Researchers Choose Hyperion Analytical

Our continual research and development has helped expand Envision NTA’s capabilities to further support nanoparticle size and distribution analysis. Learn more about our team →

Talk to a Scientist → | Request a Demo → | See the Envision NTA Instrument →

Frequently Asked Questions

What’s the smallest particle size NTA can reliably measure?

The detection limit depends on particle composition and refractive index. For high-refractive-index materials like gold or polystyrene, detection can go as low as 10–20 nm. For lower-refractive-index particles like proteins or lipids, 30–50 nm is more typical.

How does sample viscosity affect NTA measurements?

Higher viscosity slows Brownian motion, which affects size calculations. The Stokes-Einstein equation includes viscosity as a parameter, so you need to know or measure your sample’s viscosity. For aqueous solutions, this isn’t usually a problem; for organic solvents or high-concentration buffers, viscosity corrections become important.

Can NTA measure nanoparticle concentration in cells or tissue samples?

Direct measurement in intact cells isn’t possible with NTA, which requires particles suspended in liquid. NTA does excel at measuring nanoparticle uptake after cell lysis or in conditioned media for internalization studies, cells can be lysed and the lysate analyzed to quantify particle concentration. For tissue biodistribution, homogenized tissue samples may be analyzed, though extensive preparation is needed to separate particles from cellular debris.

Can NTA distinguish between different types of nanoparticles in a mixed sample without fluorescent labels?

Standard scatter-mode NTA cannot chemically distinguish particle types, a 100 nm gold nanoparticle and a 100 nm liposome will appear identical if they diffuse at the same rate. Particles with very different refractive indices scatter light with different intensities, and advanced analysis of scattering intensity distributions can sometimes resolve mixed populations, but for definitive identification, fluorescence mode NTA with selective labeling is the preferred approach.

What’s the difference between particle size and particle size distribution?

Particle size typically refers to a single value often the mean or median diameter of a sample. Particle size distribution describes the full range and spread of sizes present, revealing whether a sample is uniform (monodisperse) or heterogeneous (polydisperse). Two samples can share an identical mean size while having very different distributions and very different real-world behavior.

Why does polydispersity matter if I already know the average particle size?

An average value can mask meaningful heterogeneity. A polydisperse sample may contain multiple subpopulations with distinct biological fates, stability profiles, or performance characteristics information that’s invisible in a single mean value but directly visible in a full particle-by-particle distribution.

How do regulatory agencies use particle size distribution data?

Agencies including the FDA, EMA, and ICH expect consistent particle size distribution data not just a mean value to support claims about a nanomedicine’s stability, reproducibility, and safety throughout its lifecycle, particularly for generic or biosimilar nanomedicine comparisons where matching only the average size is insufficient.

Can NTA detect early signs of nanoparticle instability or aggregation?

Yes. Because NTA measures the full distribution rather than only an average, it can detect a slight shift toward larger particle sizes or a decrease in particle count both potential early indicators of aggregation or instability often before the change would be visible in an averaged measurement.

What causes a nanoparticle sample to appear polydisperse when it shouldn’t be?

Common causes include aggregation during storage or handling, incomplete separation during synthesis or isolation, sample preparation artifacts, or genuine biological heterogeneity (as in liposomes with multiple lamellae, or biological vesicles from mixed cell populations). Distinguishing a genuine subpopulation from a measurement artifact typically requires examining the raw particle tracking data, not just the summary distribution.

Does particle shape affect size distribution measurements?

NTA calculates a hydrodynamic diameter based on diffusion behavior, which assumes a roughly spherical particle. Non-spherical particles will report an equivalent spherical diameter that reflects their diffusion behavior rather than their literal physical dimensions in every direction a consideration worth accounting for when interpreting distribution data for irregularly shaped particles.

How many particles need to be measured for a statistically reliable distribution?

NTA’s software tracks thousands of individual particles per measurement, which provides substantially more statistical confidence for distribution analysis than techniques limited to a much smaller field of view or sample size though the exact number needed for confidence in a specific subpopulation depends on how rare that subpopulation is within the overall sample.

What does a bimodal or multimodal size distribution indicate?

A bimodal or multimodal distribution indicates the presence of two or more distinct particle populations within the same sample, for example, a monomer population alongside an aggregate population, or two genuinely different particle species. NTA’s particle-by-particle resolution is well suited to revealing and resolving these distinct modes, which ensemble techniques can blur into a single, misleading average peak.